Objective: To investigate whether calprotectin (S100A8/A9 or MRP8/14), an inflammatory complex released by monocytes, could indicate residual subclinical inflammation in rheumatoid arthritis (RA) patients who are in stable remission on disease-modifying anti-rheumatic drugs (DMARDs) and serve as a marker for disease flare after DMARD tapering.Methods: We used data from two trials. Patients from the IMPROVED study had early (< 2 years) RA, and when they achieved disease activity score remission (DAS44 < 1.6), they stopped methotrexate to attempt drug-free remission. Patients from the RETRO study had established RA in stable remission (DAS28 < 2.6) and either tapered by 50% or stopped (biological or conventional) DMARDs. Circulating calprotec...
Background: Calprotectin is a calcium binding protein with antimicrobial activity derived from neutr...
Objective S100A8/A9 (calprotectin) has shown promise as a biomarker for predicting relapse in antine...
Objective: To prospectively analyse the risk for disease relapses in patients with rheumatoid arthri...
Objectives: Calprotectin (S100A8/A9) has been correlated with disease activity in rheumatoid arthrit...
Abstract Background and Objective: Rheumatoid arthritis (RA) is an autoimmune disease defined by ch...
Background: Plasma levels of calprotectin, a major S100 leucocyte protein, are cross-sectionally ass...
Calprotectin may be a sensitive biomarker of rheumatoid arthritis (RA) disease activity.In the curre...
Aim: This meta-analysis aimed to investigate the clinical value of calprotectin in rheumatoid arthri...
Aim: This meta-analysis aimed to investigate the clinical value of calprotectin in rheumatoid arthri...
<div><p>Background</p><p>Calprotectin may be a sensitive biomarker of rheumatoid arthritis (RA) dise...
Abstract Background Calprotectin is a biomarker of disease activity in rheumatoid arthritis (RA) and...
Background Calprotectin (S100A8/S100A9 protein) is known as a damage-associated molecular pattern (D...
The search for prognostic tools for the biological treatment tapering in patients with rheumatoid ar...
Background Calprotectin is a protein released during the activation and turnover of leukocytes. It c...
Calprotectin is a heterodimer formed by two proteins, S100A8 and S100A9, which are mainly produced b...
Background: Calprotectin is a calcium binding protein with antimicrobial activity derived from neutr...
Objective S100A8/A9 (calprotectin) has shown promise as a biomarker for predicting relapse in antine...
Objective: To prospectively analyse the risk for disease relapses in patients with rheumatoid arthri...
Objectives: Calprotectin (S100A8/A9) has been correlated with disease activity in rheumatoid arthrit...
Abstract Background and Objective: Rheumatoid arthritis (RA) is an autoimmune disease defined by ch...
Background: Plasma levels of calprotectin, a major S100 leucocyte protein, are cross-sectionally ass...
Calprotectin may be a sensitive biomarker of rheumatoid arthritis (RA) disease activity.In the curre...
Aim: This meta-analysis aimed to investigate the clinical value of calprotectin in rheumatoid arthri...
Aim: This meta-analysis aimed to investigate the clinical value of calprotectin in rheumatoid arthri...
<div><p>Background</p><p>Calprotectin may be a sensitive biomarker of rheumatoid arthritis (RA) dise...
Abstract Background Calprotectin is a biomarker of disease activity in rheumatoid arthritis (RA) and...
Background Calprotectin (S100A8/S100A9 protein) is known as a damage-associated molecular pattern (D...
The search for prognostic tools for the biological treatment tapering in patients with rheumatoid ar...
Background Calprotectin is a protein released during the activation and turnover of leukocytes. It c...
Calprotectin is a heterodimer formed by two proteins, S100A8 and S100A9, which are mainly produced b...
Background: Calprotectin is a calcium binding protein with antimicrobial activity derived from neutr...
Objective S100A8/A9 (calprotectin) has shown promise as a biomarker for predicting relapse in antine...
Objective: To prospectively analyse the risk for disease relapses in patients with rheumatoid arthri...